- Strides Pharma Share Performance:
- Shares gained 2.8% on BSE, hitting an intraday high of Rs 603 per share in Tuesday’s trade.
- At 10:30 AM, shares were up 2.23% at Rs 599.10 per share.
- The BSE Sensex was up by 0.43% at 74,145.46 during the same time.
- Market capitalization of Strides Pharma stood at Rs 5,521.47 crore.
- The 52-week high was Rs 804.12 per share, and the 52-week low was Rs 329.76 per share.
- Amexel Acquisition:
- Strides Pharma Global Pte, a subsidiary in Singapore, proposed acquiring a 100% stake in Amexel Pte. Ltd., Singapore.
- The acquisition aims to create a platform for collaborations, introductions, procurement, and business engagements between pharmaceutical manufacturers and suppliers from India, China, and Southeast Asia.
- Amexel was incorporated on March 22, 2023, under Singaporean laws, and has not yet commenced operations.
- Strides Pharma Overview:
- Strides Pharma Science Limited is a global pharmaceutical company based in India.
- Specializes in generic medicines, including injectables, oral solids, and specialty products.
- Operates in over 100 countries, with strong markets in the US, Europe, and Australia.
- Product portfolio includes anti-retrovirals, oncology drugs, antibiotics, and high-value injectables.
- Operates FDA-approved state-of-the-art manufacturing facilities across India and abroad.
- Focuses on R&D to develop complex generics and specialty drugs, alongside making strategic acquisitions, like Agila Specialties.
- Performance Over the Last Year:
- Strides Pharma shares have risen 53% over the past year, while the Sensex gained 1.4%.
